Steve discusses the brand new New York State Hemp Bill with Roc NORML Political Director, Jason Klimek, Esq.

Roc NORML Executive Director Mary Kruger discusses the death of the MRTA.

Today we dive into the complex world of Cannabis banking with my guest, Kyle Taylor--an attorney who specializes in the Bank Secrecy Act and Anti-Money Laundering BSA/AML).

We discuss the challenges that banks face when working with Cannabis businesses in regards to compliance and regulatory matters. Kyle's expertise in BSA/AML provides a unique perspective on the future of Canna-banking, and what changes we can expect to see as the industry continues to move in the direction of Federal legalization. If you are a Canna-business owner, or have aspirations of becoming one, you DO NOT want to miss this episode!

Hemp is proving to be one of the most versatile, medically efficacious, lucrative crops on the planet. From CBD to HempCrete, the utilitarian value of hemp continues to rise with no sign of slowing down.

On today’s episode of #RocNORMLRadio, I sit down with the Founder and Executive Director of NYHempLab, Zach Sarkis. NYHempLab is a registered 501(c)3 not-for-profit hemp incubator located right here in Rochester, NY who’s mission is simple: to serve as an industry incubator, supporting economic growth and community development through a variety of educational events and services.

On May 24th, New York State released a new, even MORE comprehensive version of the Marijuana Regulation & Taxation Act. Roc NORML Legislative Director, Jason Klimek, provides an in-depth analysis of the current tax plan, home cultivation, and vertical integration amongst the Registered Organizations.

So what exactly happens inside your body when you consume Cannabis? Dr. Smith outlines the powerful role of the Endocannabinoid System in modulating human health, and discusses the future of Cannabis research and testing.

Harold C. Smith, Ph.D. is a cell and molecular biologist and full professor in the
Department of Biochemistry and Biophysics at the University of Rochester,
School of Medicine and Dentistry. He is a member of the Center for AIDS
Research and RNA Biology Center. He obtained his MS and Ph.D. in Cell and
Molecular Biology from the State University of New York at Buffalo in 1980 and
1982. He conducted postdoctoral fellowships in RNA biology at Baylor College of Medicine before assuming a faculty position with the University of Rochester in 1986. He is a key opinion leader in RNA biology and directs a federally and foundation funded research laboratory
from which over 141 peer-reviewed publications have emerged on biological
control mechanisms affecting diseases such as cancer, elevated cholesterol,
obesity-induced Type II diabetes and HIV/AIDS. In 2003, Dr. Smith founded
OyaGen, Inc, an Upstate NY biotech company based on ground breaking
research that revealed mechanisms within our innate ability overcome an
infection by HIV-1 and also a first in class treatment of Ebola. To date, Dr. Smith
has raised $15M in NIH and foundation funding for his academic and biotech
research and $6.5M in Angel investment. In 2016 Dr. Smith founded
Cannametrix, LLC for the development of methods to enhance cannabis testing
with cell-based testing standards that better inform patients and physicians of
potency and dose.

David Feligno discusses AgriTech in the emerging Cannabis industry and how his company, STEM Cultivation, is taking an innovative approach to vertical farming.